Get started
Author

Aruna Muthukumar

Observed names: A Muthukumar, Muthukumar, Aruna
ORCID: 0000-0001-7481-8313
Observed ORCID: 0000-0001-7481-8313
OpenAlex ID: A5009459016
Effects of risk factors for ovarian cancer in women with and without endometriosis
2022 · Minh Tung Phung, Aruna Muthukumar, et al. · Fertility and Sterility · 18
PDF
Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association
2021 · Lilah Khoja, Rachel Palmieri Weber, et al. · Gynecologic Oncology · 13
PDF
Exploring the bioactive potential of Serriatia marcescens VITAPI (Acc: 1933637) isolated from soil
2016 · Aruna Muthukumar, Pallavi Pradeep, et al. · Frontiers in Biology · 9
A Retrospective, Longitudinal Registry Study on the Long-Term Durability of Ivacaftor Treatment in People with Cystic Fibrosis
2024 · Christian Merlo, Teja Thorat, et al. · Pulmonary Therapy · 6
PDF
Herpes zoster burden in patients with asthma: real-world incidence, healthcare resource utilisation and cost
2024 · David Singer, Philippe Thompson-Leduc, et al. · BMJ Open Respiratory Research · 6
Estimating the US pericarditis prevalence using national health encounter surveillance databases
2022 · Sushil Allen Luis, Martin M. LeWinter, et al. · Current Medical Research and Opinion · 6
Impact of age at ivacaftor initiation on pulmonary outcomes among people with cystic fibrosis
2024 · Christian A Merlo, Lisa J McGarry, et al. · Thorax · 4
Mepolizumab Improves Patient-Reported Outcomes and Reduces Treatment Burden in Patients With Chronic Rhinosinusitis With Nasal Polyps: A Real-World Chart Review Study
2025 · Amy Edgecomb, Jared Silver, et al. · Journal of Allergy and Clinical Immunology · 1
Treatment Patterns and Clinical Outcomes Among Patients With Metastatic Prostate Cancer Harboring Homologous Recombination Repair Mutations
2024 · Priyanka J. Bobbili, Jasmina Ivanova, et al. · Clinical Genitourinary Cancer · 1
PDF
Clinical Outcomes in Concurrent Cohorts of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA)-Treated versus ELX/TEZ/IVA-Ineligible Individuals with Cystic Fibrosis in the US during COVID-19
2026 · Christian A. Merlo, Hela Romdhani, et al. · Pulmonary Therapy
PDF
PO:03:089 Predictors of delayed time to organ damage development in US patients with SLE treated with belimumab
2026 · Maral Dersarkissian, Yan Chen, et al.
PDF
Burden of illness and unmet needs in patients with erythropoietic protoporphyria and X-linked protoporphyria: A large US nationwide claims analysis
2025 · Maral DerSarkissian, Chelsea Norregaard, et al. · Journal of Managed Care & Specialty Pharmacy
EE279 Economic Burden of Erythropoietic Protoporphyria (EPP) and X-linked Protoporphyria (XLP): A Large United States (US) Nationwide Claims Analysis
2025 · Maral DerSarkissian, Chelsea Norregaard, et al. · Value in Health
Abstract 930: Treatment patterns and overall survival among men with metastatic castration-resistant prostate cancer harboring DDR mutations
2023 · David B. Solit, Niharika B. Mettu, et al. · Cancer Research
Abstract P4-01-30: Real-world treatment patterns and survival among adults with metastatic breast cancer with BRCA1/2 mutations
2023 · Priyanka Bobbili, Jasmina Ivanova, et al. · Cancer Research
Long-term durability of ivacaftor (IVA) treatment benefit in people with cystic fibrosis (PwCF)
2022 · C Merlo, C Scirica, et al. · 01.05 - Clinical respiratory physiology, exercise and functional imaging
Real-world outcomes among patients with epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in first-line setting.
2020 · Daniel Simmons, Maral DerSarkissian, et al. · Journal of Clinical Oncology
Abstract B32: Are ovarian cancer risk factors different for women with endometriosis?
2020 · Aruna Muthukumar, Lilah Khoja, et al. · Clinical Cancer Research
Real-world outcomes among patients with epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in first-line setting.
2020 · Daniel Simmons, Maral DerSarkissian, et al. · Journal of Clinical Oncology
Works count: 20
Citation count: 64
H-index: 6
I10-index: 2
Year
Topic
Type